ArticleFrontiers in pharmacology2019

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer.

Andrea Tomko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.